Ravi Bandaru retweeted
Behind the scenes: Cell-free DNA extraction by research associate Hailu Fu and computational analysis of cfDNA fragmentation led by first author Ravi Bandaru, a medical student.
Ravi Bandaru retweeted
Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer: doi.org/10.1172/JCI196284
Ravi Bandaru retweeted
A simple blood test may help predict which patients with head and neck cancer will benefit from immunotherapy: doi.org/10.1172/JCI196284
Ravi Bandaru @kyunkiwhynot Trisha Wise Draper @TMWiseDraper Yaping Liu @yapingliu & team @NUFeinbergMed develop a liquid biopsy that tracks fragmentation patterns of cell-free DNA across distinct genomic regions, representing a biologically meaningful, clinically actionable biomarker for the immunotherapy response in HNSCC.
The figure: cfDNA rMDS-based model predicts clinical outcomes in patients with HNSCC treated with pembrolizumab.
#HNSCC
Ravi Bandaru retweeted
Congratulations to my colleague Dr. Yapig Liu @yapingliu for developing rMDS a cfDNA fragmentomics biomarker from whole-genome sequencing data that can predict response to perioperative pembrolizumab. This method outperformed PD-L1, tumor fraction, and other fragmentomic metrics and identified patients with improved disease-free survival. #HNSCC #LiquidBiopsy #CancerResearch @NU_BMG_SQE @NUFeinbergMed @NorthwesternU @jclinicalinvest news.feinberg.northwestern.e…
Ravi Bandaru retweeted
A Northwestern study suggests that a simple #BloodTest could help identify which patients with head and neck cancer are most likely to benefit from #Immunotherapy, per @jclinicalinvest. spr.ly/6017BDZ9mJ
Ravi Bandaru retweeted
Thank you @GenomeWeb for covering our study: the variations of cfDNA end motif patterns may help predict immunotherapy response in head and neck cancer. tinyurl.com/3nn5s4yj
@NU_BMG_SQE
@NUFeinbergMed @jclinicalinvest
Very happy to share my first first-author paper in JCI. We show that cfDNA end motif entropy patterns can predict immunotherapy response in HNSCC.
Deeply grateful for @yapingliu and @TMWiseDraper for their years of mentorship and support. 🎉☺️
Our paper is out at JCI jci.org/articles/view/196284. We found that the variations of cell-free DNA end motif entropy across genomic regions predict immunotherapy response in head and neck cancer. Great collaboration with @TMWiseDraper. Congrats to @kyunkiwhynot
3
246
Ravi Bandaru retweeted
Replying to @medrxivpreprint
@medrxivpreprint Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer @UCincyMedicine @CincyResearch @NorthwesternU @TMWiseDraper @Hildy46 @yapingliu
Ravi Bandaru retweeted
Our newest preprint for the pilot study of cell-free DNA methylation as the biomarker for multiple sclerosis to simultaneously classify MS subtypes, evaluate disability severity, and predict long-term progression. Collaboration work with
@phytoclover and Dr. Zongqi Xia!
Circulating cell-free DNA methylation profiles as noninvasive multiple sclerosis biomarkers: A proof-of-concept study medrxiv.org/cgi/content/shor… #medRxiv
Ravi Bandaru retweeted
Congratulations to my excellent trainee @r_bandaru_ who just received the runner up award from Science Olympiad Alumni Research (SOAR) foundation for the research work performed in my lab!!@NU_BMG_SQE soinc.org/usafoundation
Ravi Bandaru retweeted
Want to extract fragmentation features from cfDNA WGS? Found existing code not runnable or not scalable to large dataset? Try our Finaletoolkit: extract more than ten different fragmentation features from a 100X WGS dataset (1 billion fragments) in 1.2 hours with multiple CPUs!
FinaleToolkit: Accelerating Cell-Free DNA Fragmentation Analysis with a High-Speed Computational Toolkit biorxiv.org/cgi/content/shor… #biorxiv_bioinfo














